NCR3LG1 and neoplasm: Interestingly, our clinical analysis of patient serum samples from treatment responders and non-responders revealed the highest levels of soluble B7-H6 in the serum of OAC patients with a higher tumour regression grade TRG (TRG 3–5) following CRT, which is indicative of poor treatment response.